Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

UC Davis "Lab on a Chip" Measures Heart Disease Risk

Published: Thursday, August 08, 2013
Last Updated: Thursday, August 08, 2013
Bookmark and Share
New test mimics artery conditions, detects inflammatory cells linked with atherosclerosis and myocardial infarction.

Using a special microchip that can perform laboratory functions, a team of cardiologists and biomedical engineers from UC Davis has identified cells linked with inflammation and varying degrees of heart disease.

The “lab on a chip,” which is based on technology used to evaluate chemicals and cell-to-cell interactions, may one day lead to a rapid test that doctors could use to better predict, treat and monitor atherosclerosis.

The study is published online in the Proceedings of the National Academy of Sciences of the United States of America.

“Our test provides a good indication of how atherosclerosis actually develops inside coronary arteries,” said Scott Simon, professor of biomedical engineering and a study co-author. “This is an exciting step in developing personalized profiles for heart disease risk.”

Cardiologists agree that inflammation plays an important role in heart disease, but knowing how inflammation affects the risk of a heart attack is a challenge – hence the phenomenon of a patient leaving the doctor’s office with a clean bill of health only to have a heart attack a week later.

“Inflammation likely accounts for aspects of heart disease that traditional indicators such as hypertension, diabetes, smoking and cholesterol don’t assess,” said Ehrin Armstrong, an interventional cardiologist and senior author of the study. “This test measures inflammation in cells of the immune system, opening up new avenues to monitor and treat cardiovascular disease.”

The investigators focused on specific white blood cells called CD14++ and CD16+ monocytes that link in the blood with triglycerides – fats that are risk factors for atherosclerosis. These monocytes become activated by “swallowing” triglycerides and expressing proteins called integrins. While integrins help protect against infection, they also make the monocytes sticky, helping them easily adhere to endothelial cells that line the inner surfaces of blood vessels and promoting plaques that clog arteries and lead to cardiac events.

The team used the “lab on a chip” to study the blood of 35 volunteers with varied levels of baseline triglycerides but who were otherwise healthy, along with the blood of 18 volunteers who each had experienced a heart attack. The small device – only a few square inches in area – forces blood to flow at a speed similar to blood in arteries over a specially treated glass slide that serves as a molecular substrate that models artery walls. The blood is then analyzed using a microscope that detects the relative levels of CD14++, CD16+ and integrins that stick to the substrate.

“Our lab-on-a-chip is unique in that it mimics the conditions in an actual artery during the early stages of atherosclerosis,” said Simon, who developed the technology used in the study.

After eating a high-fat meal to induce an inflammatory state, the blood of the healthy volunteers with varying triglyceride levels revealed that the monocytes had adhered to the chip substrate with sevenfold higher efficiency than other cells, proving that they are accurate biomarkers of inflammation. Further investigation showed that the increased monocyte adhesion was due to increased expression of a specific integrin known as CD11c, which was upregulated after the high-fat meal.

The evaluation of blood samples from patients who had experienced a heart attack showed that levels of CD14++ and CD16+ monocyte adhesion due to the integrin CD11c increased by 100 percent when compared to levels of these cells in the blood of healthy volunteers, indicating that these biomarkers increased proportionate to the level of cardiac disease.

“We can actually see how monocytes in the blood of people with different risks for atherosclerosis and heart attack – ranging from people with low to high triglyceride levels to those who had actually experienced a cardiac event – interact with this model of the artery wall,” said Armstrong. “We are coming close to observing atherosclerosis in action at a personal level.”

The lab-on-a-chip may one day be used to provide a rapid risk assessment tool that could be used in doctors’ offices. It may also be useful as a tool for further research in therapeutics.

“Interventions that target monocyte activation could reduce progression of atherosclerosis. In patients who have already had a heart attack, it is possible that such interventions could also reduce long-term injury to the heart,” said Armstrong.

The interdisciplinary team plans to carry the investigations further to refine their understanding of the cellular mechanisms of atherosclerosis. They would also like to conduct studies on larger populations over long time periods to better determine the predictive utility of the test.

Funding for the study was provided by the National Heart, Lung, and Blood Institute and with a Clinical Research Program Award from the American Heart Association.

Other study authors, all from UC Davis, are Greg Foster and Robert Michael Gower of the Department of Biomedical Engineering, and Kimber Stanhope and Peter Havel of the Department of Nutrition and Department of Molecular Biosciences, School of Veterinary Medicine.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Thursday, August 20, 2015
UC Davis to Establish Food Safety Center in China
Officials from the city of Zhuhai, China, and the University of California, Davis, have signed a memorandum of understanding to establish the World Food Center-China.
Monday, June 01, 2015
Nanomaterials In Sunscreens And Boats Leave Marine Life Vulnerable
Study shows that sea urchin embryos are more vulnerable to toxins when exposed to nanomaterials.
Thursday, May 14, 2015
Milk Protein Comparison Unveils Nutritional Gems For Developing Babies
The study revealed the first comprehensive macaque milk proteome and newly identified 524 human milk proteins.
Tuesday, March 17, 2015
Keck Foundation Grant Awarded to UC Davis Researcher
Grant will help fund biomedical project, "In Vivo 3D Imaging Using Bioluminescent Gene Reporters and MRI."
Monday, March 10, 2014
High Good and Low Bad Cholesterol Levels are Healthy for the Brain
Study suggests a potential new approach to lowering the prevalence of Alzheimer's disease.
Friday, January 03, 2014
Cancer Drug Unties Knots in the Chromosome that Causes Angelman and Prader-Willi Syndromes
Researchers have identified how and where in the genome a cancer chemotherapy agent acts on and ‘un-silences’ the epigenetically silenced gene that causes Angelman syndrome.
Thursday, August 08, 2013
UC Davis Helps Global Team Sequence Chickpea Genome
An international team of scientists has sequenced the genome of the chickpea, a critically important crop in many parts of the world, especially for small-farm operators in marginal environments of Asia and sub-Saharan Africa.
Wednesday, January 30, 2013
UC Davis Receives $9.3 Million Grant for Metabolomics Center
The new center will bring together existing UC Davis service facilities in mass spectrometry, nuclear magnetic resonance and imaging.
Monday, September 10, 2012
Sequencing of 100,000 Pathogens to Help Solve Foodborne Outbreaks
New collaboration of Federal agencies with UC Davis and Agilent Technologies.
Friday, August 24, 2012
New DNA Repair Pathway
UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.
Monday, November 08, 2010
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos